Peripheral site ligands accelerate inhibition of acetylcholinesterase by neutral organophosphates.

Article Details

Citation

Copy to clipboard

Radic Z, Taylor P

Peripheral site ligands accelerate inhibition of acetylcholinesterase by neutral organophosphates.

J Appl Toxicol. 2001 Dec;21 Suppl 1:S13-4.

PubMed ID

11920914 [ View in PubMed

]

Abstract

The rates of inhibition of mouse acetylcholinesterase (AChE; EC 3.1.1.7) by paraoxon, haloxon, DDVP and enantiomers of neutral alkyl methylphosphonyl thioates and cationic alkyl methylphosphonyl thiocholines were measured in the presence and absence of AChE peripheral site inhibitors: gallamine, d-tubocurarine, propidium, atropine and derivatives of coumarin. All ligands, except the coumarins, at submillimolar concentrations enhanced the rates of inhibition by neutral organophosphates, whereas inhibition rates by cationic organophosphates were decreased. When peripheral site ligand concentrations extended to millimolar concentrations the extent of the enhancement decreased, creating a well-shaped activation profile. Analysis of inhibition by DDVP revealed that peripheral site inhibitors increase the second-order reaction rates by increasing maximal rates of phosphorylation. These observations suggest that peripheral site ligands are capable of allosterically affecting the conformation of residues in the choline binding site of AChE, thus optimizing the position of the leaving group of uncharged organophosphates during the inhibition reaction.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Gallamine triethiodide	Acetylcholinesterase	Protein	Humans	Yes	Inhibitor	Details
Tubocurarine	Acetylcholinesterase	Protein	Humans	Unknown	Inhibitor	Details